After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Relay Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $10.48 and fluctuated between $10.64 as its day high and $10.12 as its day low. The current market capitalization of Relay Therapeutics Inc is $1.34B. A total of 0.66 million shares were traded on the day, compared to an average of 1.04M shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, RLAY has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 4 BUYs and 29 SELLs from insiders. Insiders purchased 166,370 shares during that period but sold 44,605.
In the most recent transaction, Bergstrom Donald A sold 3,178 shares of RLAY for 9.64 per share on Jan 29. After the transaction, the President, R&D now owns 530,878 company shares. In a previous transaction on Jan 29, Catinazzo Thomas sold 2,005 shares at 9.64 per share. RLAY shares that Chief Financial Officer owns now total 341,846.
Among the insiders who sold shares, Adams Brian disposed of 1,929 shares on Jan 29 at a per-share price of $9.64. This resulted in the Chief Legal Officer holding 327,738 shares of RLAY after the transaction. In another insider transaction, Rahmer Peter sold 1,651 shares at $9.64 per share on Jan 29. Company shares held by the insider now total 514,977.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for RLAY in the last 3 months, the mean price target is $22.96 with high estimates of $33.00 and low estimates of $10.60. In terms of 52-week highs and lows, RLAY has a high of $19.54 and a low of $5.95.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RLAY’s latest balance sheet shows that the firm has $958.07M in Cash & Short Term Investments as of fiscal 2021. There were $22.90M in debt and $24.32M in liabilities at the time. Its Book Value Per Share was $6.32, while its Total Shareholder’s Equity was $897.81M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RLAY is Buy with a score of 4.64.
